It was reported that miR-145 regulated different targets, including MUC13, TGF-β receptor and SMAD2, and slowed pancreatic cancer progression by impeding the proliferation, migration, and invasion of cancer cells [42,43,44]. This evidence concerns the gene SMAD2 and cancer.